TG Therapeutics Inc

TGTX

Market Cap$2.15B

Close$

Compare TG Therapeutics

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
TG Therapeutics Inc	164.6	0%	8%	13.7	0.6
Market Avg	58.9	1.29%	29%	-	1
Healthcare Avg	66.3	1.31%	15%	-	0.9

$16.18

Current Fair Value

18.5% upside

Undervalued by 18.5% based on the discounted cash flow analysis.

Share Statistics

Market cap	$2.15 Billion
Enterprise Value	$2.03 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$0.09
Beta	0.0
Outstanding Shares	154,542,945
Avg 30 Day Volume	2,689,354

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	164.58
PEG	-223.81
Price to Sales	13.66
Price to Book Ratio	13.66
Enterprise Value to Revenue	8.7
Enterprise Value to EBIT	98.5
Enterprise Value to Net Income	155
Total Debt to Enterprise	0.05
Debt to Equity	0.62

Revenue Sources

No data

ESG Score

No data

About TG Therapeutics Inc

CEO: Michael Weiss